logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Bioreference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

Aug 16, 2021•over 4 years ago

Acquiring Company

BioReference Health

Acquired Company

U.S. Ariosa Centralized Laboratory Prenatal Testing Business

Elmwood ParkMedicalBiotechnology

Description

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche.

Company Information

Company

BioReference Health

Location

Elmwood Park, New Jersey, United States

About

BioReference is at the center of progress for patient care, providing laboratory testing and clinical diagnostic services. It offers a comprehensive test menu and unparalleled expertise and client service to healthcare providers, hospitals, integrated delivery networks, and physician offices. BioReference is a wholly owned subsidiary of OPKO Health, Inc.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed